Your browser doesn't support javascript.
loading
Development of a Test System to Detect the Omicron Variant of SARS-CoV-2 and the Frequency of Its Detection in Patients.
Filipenko, M L; Oskorbin, I P; Shamovskaya, D V; Kharpov, E A; Stepanov, A A; Romanov, V V; Kuznetsov, V V; Boyarskikh, U A; Kechin, A A; Pechkovsky, E V; Krivoruchko, A B; Ivanov, A M; Kushlinskii, N E; Vlasov, V V.
Afiliação
  • Filipenko ML; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia. mlfilipenko@gmail.com.
  • Oskorbin IP; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
  • Shamovskaya DV; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
  • Kharpov EA; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
  • Stepanov AA; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
  • Romanov VV; SKR-Test Company, Iskitim, Russia.
  • Kuznetsov VV; SKR-Test Company, Iskitim, Russia.
  • Boyarskikh UA; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
  • Kechin AA; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
  • Pechkovsky EV; Modern Laboratory Technologies Company, Koltsovo, Novosibirsk region, Russia.
  • Krivoruchko AB; S. M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, St. Petersburg, Russia.
  • Ivanov AM; S. M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, St. Petersburg, Russia.
  • Kushlinskii NE; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia.
  • Vlasov VV; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
Bull Exp Biol Med ; 173(2): 229-234, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35737161
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Bull Exp Biol Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Federação Russa
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Bull Exp Biol Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Federação Russa